In the News

Asbestos Legislation: Bruce Vento Ban Asbestos and Prevent Mesothelioma Act

February 28th, 2008. After six years, the U.S. Senate finally, and unanimously, passed Senator Patty Murray's Ban Asbestos in America Act last October. The act prohibits asbestos where present at more than 1% by weight, calls for a public education campaign about the dangers of asbestos exposure, and directs critically-needed federal research to ... [More >>]

Posted in Asbestos & Mesothelioma Lawsuits, Personal Injury, Toxic Torts/Harmful Chemical Exposures

CDC: Investigation of Progressive Inflammatory Neuropathy Among Swine Slaughterhouse Workers - Minnesota, 2007 & 2008

January 31st, 2008. (Press Release) Working case definition for progressive inflammatory neuropathy among swine slaughterhouse workers, 2007–2008 Epidemiologic criterion Participation in or close exposure to commercial or private swine-slaughtering operations. Clinical criteria ... [More >>]

Posted in Personal Injury, Worker's Compensation - Occupational Diseases

Quality Pork Processor Worker Neurological Illnesses Update

January 16th, 2008. (Press Release) The Minnesota Department of Health has learned that the Indiana Department of Health and CDC are investigating illnesses in several plant workers at a pig slaughtering plant in Indiana to determine if their illnesses are similar to what has been found in Minnesota. MDH continues ... [More >>]

Posted in Personal Injury, Worker's Compensation - Occupational Diseases

Minnesota health officials investigate illnesses at Quality Pork Processors in Austin; No evidence to suggest general public or food supply at risk

December 3rd, 2007. (Press Release) The Minnesota Department of Health (MDH) is investigating a cluster of 11 cases of neurological illness in workers at Quality Pork Processors, Inc. (QPP) in Austin, Minn. QPP staff and physicians in the Austin and Rochester area recently realized there had been a pattern of cases of ... [More >>]

Posted in Personal Injury, Worker's Compensation - Occupational Diseases

FDA Adds Boxed Warning for Heart Attacks to Anti-Diabetes Drug Avandia; Agency says drug to remain on market, while safety assessment continues

November 14th, 2007. (Press Release) The U.S. Food and Drug Administration announced today that the manufacturer of Avandia (rosiglitazone), a drug used to treat type 2 diabetes, has agreed to add new information to the existing boxed warning in the drug's labeling about potential increased risk for heart attacks. People with type 2 diabetes who have ... [More >>]

Posted in Avandia, Harmful Drug Exposure, Personal Injury, Product Liability

Defribrillator leads recall: Sprint Fidelis lead fractures

October 24th, 2007. Distribution of two types of defibrillators, Implantable cardioverter defibrillators (ICDs) and Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds), is being suspended by Medtronic as a result of lead fractures. If a lead fractures, defibrillators may deliver unecessary shocks or may not function at all. Issues with the leads was first ... [More >>]

Posted in Personal Injury, Product Liability, Sprint Fidelis Defibrillator Leads

FDA: Statement on Medtronic’s Voluntary Market Suspension of Their Sprint Fidelis Defibrillator Leads

October 22nd, 2007. (Press Release) Statement by Daniel Schultz, M.D., director of the Center for Devices and Radiological Health: Medtronic's decision to voluntarily remove its Sprint Fidelis defibrillation leads from the market is in the best interest of patient safety. These electronic wires are prone to fracture in a small number of patients which ... [More >>]

Posted in Personal Injury, Product Liability, Sprint Fidelis Defibrillator Leads

Defect in Sprint Fidelis Defibrillation Leads; Medtronic Halts Distribution

October 19th, 2007. (Press Release) On Monday, October 15, Medtronic, Inc. said voluntarily suspended worldwide distribution of the Sprint Fidelis® family of defibrillation leads because of the potential for lead fractures. In addition, the company recommends against new implants of the leads (Sprint Fidelis Models: 6930, 6931, 6948, 6949). The Sprint ... [More >>]

Posted in Personal Injury, Product Liability, Sprint Fidelis Defibrillator Leads

Study: diabetics better off avoiding new drugs in favor of cheaper, safer old ones

July 17th, 2007. A new study published in the Annals of Internal Medicine finds that most type-2 diabetics are better off using older, cheaper diabetes drugs than their heavily advertised, newer counterparts. With the exception of those who cannot tolerate specific drugs like Glucophage (metformin), the effectiveness of the older medications was on ... [More >>]

Posted in Avandia, Harmful Drug Exposure, Personal Injury, Product Liability

Failure-to-warn? Avandia may increase risk of heart attack by 43%

June 29th, 2007. One million type two diabetics in the US, and nearly 6 million worldwide, who take Avandia (rosiglitazone maleate) may be putting themselves at an increased risk of heart attack. Earlier this spring, The New England Journal of Medicine released a study by Dr. Steven Nissen that analyzed the combined results ... [More >>]

Posted in Avandia, Harmful Drug Exposure, Personal Injury, Product Liability

« Previous Headlines

Copyright 2003 Goldberg, Persky & White, P.C. The information provided by or linked to from this web site is intended to educate and inform victims of asbestos-related disease and other occupational injuries. The Goldberg, Persky & White, P.C. web site is intended for informational purposes only and is not to be construed as medical or legal advice. Visitors who are in need of legal or medical advice should consult with a professional licensed in their state of residence. The opinions expressed herein by persons or organizations other than Goldberg, Persky & White, P.C. are not necessarily endorsed by Goldberg, Persky & White, P.C. No attorney-client relationship is established by visiting our website or sending us Email. Copyright (c) 2003, Goldberg, Persky & White, P.C. All Rights Reserved.